Prognostic Intake of Molecular Markers in Lung Cancer The Pulmonologist Point Of View

1. Ferlay, J., Shin, H. R., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer, 127(12), 2893-2917.10.1002/ijc.2551621351269Search in Google Scholar

2. Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E. & Forman, D. (2011). Global cancer statistics. CA: a cancer journal for clinicians, 61(2), 69-90.10.3322/caac.2010721296855Open DOISearch in Google Scholar

3. Powell, H.A. & Baldwin, D.R. (2014). Multidisciplinary team management in thoracic oncology: more than just a concept? Eur Respir J, 43(6), 1776-1786. doi: 10.1183/09031936.00150813Search in Google Scholar

4. Detterbeck, F. C., Boffa, D. J., Kim, A. W., & Tanoue, L. T. (2017). The Eighth Edition Lung Cancer Stage Classification. CHEST Journal, 151(1), 193-203..10.1016/j.chest.2016.10.01027780786Search in Google Scholar

5. Goldstraw, P., Chansky, K., Crowley, J., Rami- Porta, R., Asamura, H., Eberhardt, W. E., ... & Rami-Porta, R. (2016). The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. Journal of Thoracic Oncology, 11(1), 39-51.10.1016/j.jtho.2015.09.00926762738Open DOISearch in Google Scholar

6. Lindeman, N.I., Cagle, P.T., Beasley, M.B., Chitale, D.A., Dacic, S., Giaccone, G., Jenkins, R.B., Kwiatkowski, D.J., Saldivar , J.S., Squire, J., Thunnissen, E. & Ladanyi, M. (2013). Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. Arch Pathol Lab Med. 137(6), 828-60. doi: 10.5858/arpa.2012-0720-OA.Search in Google Scholar

7. Lista protocoalelor terapeutice cu modificarile si completarile ulterioare. (2017). Retrieved from http://www.cnas.ro/Search in Google Scholar

8. Kris, M.G., Johnson, B.E., Berry, L.D., Kwiatkowski, D.J., Iafrate, A.J., Wistuba, I.I., Varella-Garcia, M., Franklin, W.A., Aronson, S.L. & Su, P.-F. (2014). Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. Jama, 311(19), 1998-2006. doi: 10.1001/jama.2014.3741.Search in Google Scholar

9. Diaz Jr, L.A. & Bardelli, A. (2014). Liquid biopsies: genotyping circulating tumor DNA. Journal of clinical oncology, 32(6), 579-586. .10.1200/JCO.2012.45.2011482076024449238Search in Google Scholar

10. Sequist, L.V., Neal, W.N. (2017). Personalized, genotype-directed therapy for advanced nonsmall cell lung cancer. UpToDate 2017Search in Google Scholar

11. Kerr, K.M., Bubendorf, L., Edelman, M.J., Marchetti, A., Mok, T., Novello, S., O'Byrne, K., Stahel, R., Peters, S. & Felip, E. (2014). Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer. Annals of Oncology, 25(9), 1681-1690. doi: 10.1093/annonc/mdu145Search in Google Scholar

12. Leighl, N.B., Rekhtman, N., Biermann, W.A., Huang, J., Mino-Kenudson, M., Ramalingam, S.S., West, H., Whitlock, S. & Somerfield, M.R. (2014). Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the College of American Pathologists/International Association for the study of lung cancer/association for molecular pathology guideline. Journal of clinical oncology, 32(32), 3673-3679.10.1200/JCO.2014.57.3055532108925311215Search in Google Scholar

13. Oxnard, G.R., Thress, K.S., Alden, R.S., Lawrance, R., Paweletz, C.P., Cantarini, M., Yang, J.C.-H., Barrett, J.C. & Jänne, P.A. (2016). Association between plasma genotyping and outcomes of treatment with osimertinib (AZD9291) in advanced non-small-cell lung cancer. Journal of clinical oncology, 34(28), 3375-3382.10.1200/JCO.2016.66.7162503512327354477Search in Google Scholar